VolitionRX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VolitionRX and other ETFs, options, and stocks.About VNRX
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids.
CEOCameron John Reynolds
CEOCameron John Reynolds
Employees85
Employees85
HeadquartersHenderson, Nevada
HeadquartersHenderson, Nevada
Founded1998
Founded1998
Employees85
Employees85
VNRX Key Statistics
Market cap31.50M
Market cap31.50M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume2.79M
Average volume2.79M
High today$0.269
High today$0.269
Low today$0.2415
Low today$0.2415
Open price$0.2541
Open price$0.2541
Volume1.37M
Volume1.37M
52 Week high$0.94
52 Week high$0.94
52 Week low$0.2335
52 Week low$0.2335
Stock Snapshot
VolitionRX(VNRX) stock is priced at $0.25, giving the company a market capitalization of 31.5M. It carries a P/E multiple of -1.11.
During the trading session on 2025-12-25, VolitionRX(VNRX) shares reached a daily high of $0.27 and a low of $0.24. At a current price of $0.25, the stock is +5.2% higher than the low and still -5.5% under the high.
Trading volume for VolitionRX(VNRX) stock has reached 1.37M, versus its average volume of 2.79M.
The stock's 52-week range extends from a low of $0.23 to a high of $0.94.
The stock's 52-week range extends from a low of $0.23 to a high of $0.94.
People also own
Based on the portfolios of people who own VNRX. This list is generated using Robinhood data, and it’s not a recommendation.